ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Abeona Therapeutics, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -31.06% of over the last 5 years
2
Flat results in Jun 26
- OPERATING CASH FLOW(Y) Lowest at USD -76.44 MM
- PRE-TAX PROFIT(Q) At USD -13 MM has Fallen at -183.93%
- NET PROFIT(Q) At USD -13 MM has Fallen at -184.99%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 6.20%, its profits have risen by 202.2% ; the PEG ratio of the company is 0
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Abeona Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Abeona Therapeutics, Inc.
0.36%
0.57
53.54%
S&P 500
15.76%
1.22
13.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-10.26%
EBIT Growth (5y)
-31.06%
EBIT to Interest (avg)
-26.41
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.56
Sales to Capital Employed (avg)
0.13
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
92.40%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
1.54
EV to EBIT
-0.83
EV to EBITDA
-0.86
EV to Capital Employed
-6.58
EV to Sales
12.76
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
40.43%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
NET SALES(HY)
Higher at USD 20.1 MM
RAW MATERIAL COST(Y)
Fallen by -147.84% (YoY
CASH AND EQV(HY)
Highest at USD 315.1 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 3.13 times
DEBTORS TURNOVER RATIO(HY)
Highest at 4.43 times
OPERATING PROFIT(Q)
Highest at USD -12.82 MM
-19What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -76.44 MM
PRE-TAX PROFIT(Q)
At USD -13 MM has Fallen at -183.93%
NET PROFIT(Q)
At USD -13 MM has Fallen at -184.99%
DEBT-EQUITY RATIO
(HY)
Highest at -99.14 %
Here's what is working for Abeona Therapeutics, Inc.
Net Sales
At USD 20.1 MM has Grown at 4,925%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Sales
Higher at USD 20.1 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Operating Profit
Highest at USD -12.82 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Cash and Eqv
Highest at USD 315.1 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 3.13 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 4.43 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -147.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Abeona Therapeutics, Inc.
Pre-Tax Profit
At USD -13 MM has Fallen at -183.93%
over average net sales of the previous four periods of USD 15.49 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -13 MM has Fallen at -184.99%
over average net sales of the previous four periods of USD 15.3 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -76.44 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Highest at -99.14 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading
